All Stories

Avidity's latest DMD data drop assuages safety concerns for RNA-based asset: analyst

After some earlier data sparked questions from analysts, Avidity Biosciences has released more data for its RNA-based Duchenne muscular dystrophy candidate.

Mar 17, 2025 - 19:02
 0
Avidity's latest DMD data drop assuages safety concerns for RNA-based asset: analyst
After some earlier data sparked questions from analysts, Avidity Biosciences has released more data for its RNA-based Duchenne muscular dystrophy candidate.
Read More

Tags:

Previous Article

Flagship-backed Apriori Bio lays off employees, shifts focus to pipeline develop...

Next Article

Why Louis Vuitton Went Back to Murakami

Related Posts

Charles River lays off staffers at Memphis cell therapy manufacturing site

Charles River lays off staffers at Memphis cell therapy...

Feb 19, 2025  0

Atara, reeling from FDA hold on Ebvallo, lays off half of workforce

Atara, reeling from FDA hold on Ebvallo, lays off half ...

Mar 4, 2025  0

VC firm Sofinnova brings in 1.6B euros over a year to fund up to 60 life sciences companies

VC firm Sofinnova brings in 1.6B euros over a year to f...

Mar 4, 2025  0